During the past decade, IPC Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IPC Research" are "Adjunctive Treatment of Major Depressive Disorder" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Agitation in Participants With Dementia of the Alzheimer's Type" (1 trials), "Alzheimer Disease" (1 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "IPC Research" in a lesser frequency.

Most popular intervention types in "IPC Research" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Pimavanserin" (3 trials), "AVP-786" (2 trials), "AVP-786-18" (1 trials) and "AVP-786-28" (1 trials). Other intervention names were less common.

The vast majority of trials in "IPC Research" are 8 trials for "All" genders.

Currently, there are NaN active trials in "IPC Research". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in IPC Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in IPC Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".